Paper Review Records
All Paper Review Records
12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
180
days
A cohort of allogeneic hematopoietic stem cell transplantation for pediatric rare diseases (allo-HSCT-PRD): design and preliminary results
AuthorsShiwen Hu; Ping Wang; Zifeng Li; Wenjin Jiang; Lian Liu; Wenjuan Ma; Ying Huang; Xiaochuan Wang; Xiaonan Du; Xiaowen Qian; Hongsheng Wang; Yi Wang; Yunhui Zhang; Xiaowen Zhai
Affiliations1. Department of Hematology and Oncology, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China; 2. Management of Science and Technology, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China; 3. Department of Gastroenterology, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China; 4. Department of Clinical Immunology, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China; 5. Department of Neurology, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, China; 6. Key Laboratory of Health Technology Assessment, National Health Commission of the People’s Republic of China, Fudan University, Shanghai, China; 7. Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai, China
526
days
Prognostic factors and effect modifiers in patients with relapsed or refractory follicular lymphoma who failed at least two lines of therapy: a systematic literature and expert clinical review
AuthorsPau Abrisqueta; Ana Jiménez-Ubieto; Ángel Serna; Irene Zamanillo; Yuting Kuang; Jennifer Uyei; Mohsin Shah; Laura Walsh; Eileen Thorley; Krystal Cantos; Emaan Rashidi; Qiufei Ma; Jessica J. Jalbert; Alexi N. Archambault; Yingxin Xu; Shivani Aggarwal; Srikanth Ambati; Hesham Mohamed; Christian Hampp; Bastian von Tresckow
Affiliations1. Department of Hematology, Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain; 2. Hematology Department, University Hospital 12 de Octubre, Madrid, Spain; 3. IQVIA, Inc., Durham, USA; 4. Regeneron Pharmaceuticals, Inc., Tarrytown, USA; 5. Department of Hematology and Stem Cell Transplantation, West German Cancer Center, and German Cancer Consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days